Similarly to what demonstrated in lymphoma cells [34], we provided evidence that, also in myeloma cells undergoing p53-dependent apoptosis, AKT is downregulated by a caspase-dependent mechanism. The gene discussed is AKT1; the disease is plasma cell myeloma.